Skip to main content
. Author manuscript; available in PMC: 2020 Nov 30.
Published in final edited form as: Mol Pharm. 2019 Feb 26;16(4):1620–1632. doi: 10.1021/acs.molpharmaceut.8b01297

Table 2.

Five-fold cross validation statistical significance (p-value) using different scores. A. Rank normalized score (pairwise; Wilcoxon matched-pairs signed rank test), B. Rank normalized score (Unpaired Comparison; Mann-Whitney U test), C. ΔRNS (Unpaired Comparison; Mann-Whitney U test). Assay Central (AC); AdaBoost (ada); Bernoulli Naïve-Bayes (bnb); k-nearest neighbors (knn); Random Forest (rf); support vector classification (svc); Deep Neural Networks (DL).

A.
ada bnb DL knn rf svc AC
ada N/A 0.0078** 0.1094 0.0078** 0.0078** 0.0078** 0.0156*
bnb 0.0078** N/A 0.0391* 0.0078** 0.0078** 0.0078** 0.0078**
DL 0.1094 0.0391* N/A 0.5469 0.6406 0.1953 0.6406
knn 0.0078** 0.0078** 0.5469 N/A 0.0781 0.5469 0.1953
rf 0.0078** 0.0078** 0.6406 0.0781 N/A 0.1953 0.9453
svc 0.0078** 0.0078** 0.1953 0.5469 0.1953 N/A 0.3125
AC 0.0156* 0.0078** 0.6406 0.1953 0.9453 0.3125 N/A
B.
ada bnb DL knn rf svc AC
ada N/A 0.1949 0.3281 0.1049 0.1605 0.1049 0.1605
bnb 0.1949 N/A 0.1304 0.0499* 0.1304 0.0281* 0.0830
DL 0.3281 0.1304 N/A 0.9591 0.7984 0.6454 0.7984
knn 0.1049 0.0499* 0.9591 N/A 0.3823 0.7984 0.5737
rf 0.1605 0.1304 0.7984 0.3823 N/A 0.4418 0.9591
svc 0.1049 0.0281* 0.6454 0.7984 0.4418 N/A 0.5737
AC 0.1605 0.0830 0.7984 0.5737 0.9591 0.5737 N/A
C.
ada bnb DL knn rf svc AC
ada N/A 0.1949 0.0207* 0.0011** 0.0281* 0.0095** 0.0626
bnb 0.1949 N/A 0.0047** 0.0002*** 0.0002*** 0.0065** 0.0068**
DL 0.0207* 0.0047** N/A 0.5526 0.4418 0.1183 0.8527
knn 0.0011** 0.0002*** 0.5526 N/A 0.0626 0.3579 0.1790
rf 0.0281* 0.0002*** 0.4418 0.0626 N/A 0.0443* 0.8527
svc 0.0095** 0.0065** 0.1183 0.3579 0.0443* N/A 0.2171
AC 0.0626 0.0068** 0.8527 0.1790 0.8527 0.2171 N/A